KeyGene and its parent firm, KeyGene NV, were named as defendants in a NuGen Technologies suit seeking to invalidate two US patents.
LGC will offer NuGen's single-primer enrichment technology for next-generation sequencing target enrichment.
The companies will integrate Cambridge's TrueMethyl technology for oxidative bisulfite sequencing with NuGen's sequencing library preparation kits.
The new workflow, which was validated across three separate laboratories in New Jersey, is a critical step toward standardizing the use of RNA-seq in clinical genomics.
The firm is developing new applications for the technology, including one that will integrate targeted panels and copy number analysis into a single assay.
The partners will conduct a study to show the firms' technologies can help increase blood sample integrity and sequencing efficiency.
Nikon Research Corporation of America has been awarded
HandyLab has been awarded
IdentiGen recently announced the availability of a novel SNP genotyping assay chemistry called IdentiSNP that it claims confers major advantages over current commercial alternatives.
NuGen Technologies this week announced the release of the Ovation Human FFPE RNA-seq Multiplex System.
Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.
CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.
The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.